{"id":"W2786821373","doi":"10.1007/s11938-018-0175-1","title":"Novel Therapies and Treatment Strategies for Patients with Inflammatory Bowel Disease","year":2018,"lang":"en","type":"review","venue":"Current Treatment Options in Gastroenterology","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":70,"is_retracted":false,"has_abstract":false,"ca_institutions":"Robarts Clinical Trials; Western University","funders":"Janssen Biotech; Allergan; Baxter Healthcare Corporation; Genentech; Gilead Sciences; Ablynx; Biogen; Celgene; Novo Nordisk; Teva Pharmaceutical Industries; ActoGeniX; Sanofi; Amgen; Pfizer; Ironwood Pharmaceuticals, Incorporated; Eli Lilly and Company","keywords":"Medicine; Ustekinumab; Vedolizumab; Natalizumab; Inflammatory bowel disease; Drug; Clinical trial; Disease; Pharmacology; Immunology; Intensive care medicine; Internal medicine; Adalimumab","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004851954,0.0006965393,0.001383719,0.001099747,0.000216336,0.0008901156,0.0006857481,0.0009477653,0.003397095],"category_scores_gemma":[0.0007855252,0.0001722557,0.0005342374,0.0007706562,0.0003971856,0.0009261425,0.0006349515,0.002261658,0.00111083],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002878508,"about_ca_system_score_gemma":0.0006778952,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004355322,"about_ca_topic_score_gemma":0.00115295,"domain_scores_codex":[0.9998432,0.00003431694,0.00002340803,0.00002416765,0.00005294476,0.0000219185],"domain_scores_gemma":[0.9997413,0.000140373,0.00003966158,0.000007088141,0.00004842701,0.00002319095],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001475516,0.00009636281,0.0002469824,0.008631567,0.00008265333,0.0002353474,0.00003158568,0.0003150495,0.001270885,0.002632424,0.02140488,0.9649048],"study_design_scores_gemma":[0.000124439,0.000242703,0.001368404,0.007216061,0.000346788,0.002191904,0.00009441246,0.0002612713,0.0006763425,0.004919762,0.982525,0.00003285316],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001274737,0.9983606,0.0001871497,0.000438296,0.0001999706,0.000003852538,0.00001676559,0.000006983281,0.0006590523],"genre_scores_gemma":[0.001247575,0.9968398,0.0004833807,0.0004810629,0.0003922011,0.00000996666,0.00004400538,0.000001997334,0.0004999966],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.003397095,"threshold_uncertainty_score":0.01136446,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02647416217574117,"score_gpt":0.3008999525957434,"score_spread":0.2744257904200023,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}